Overview

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Status:
Completed
Trial end date:
1999-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to measure the continued efficacy of apomorphine after previous exposure of at least three months duration.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Treatments:
Apomorphine